Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank69
3Y CAGR-52.0%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-52.0%/yr
Quarterly compound
Percentile
P69
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 11.61% |
| Q3 2025 | 5.76% |
| Q2 2025 | 48.31% |
| Q1 2025 | -21.82% |
| Q4 2024 | 25.80% |
| Q3 2024 | 14.35% |
| Q2 2024 | 11.98% |
| Q1 2024 | 7.15% |
| Q4 2023 | 7.69% |
| Q3 2023 | 17.08% |
| Q2 2023 | 67.59% |
| Q1 2023 | 30.48% |
| Q4 2022 | 105.18% |
| Q3 2022 | -52.75% |
| Q2 2022 | 505.21% |
| Q1 2022 | -17.56% |
| Q4 2021 | 76.75% |
| Q3 2021 | 275.18% |
| Q2 2021 | 682.86% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |